在肝移植之前接受冠状动脉再血管化的无症状患者的结果
Goyal Umadat1, Jennifer Lee2, Jordan C Ray1
1Division of Cardiovascular Diseases, Mayo Clinic Florida, Jacksonville, FL 32224, USA.
Journal of clinical medicine
|October 16, 2025
概括
移植前皮肤冠状动脉干预 (PCI) 在无症状肝移植 (LT) 候选人中没有减少严重冠状动脉疾病 (CAD) 的重大心血管不良事件 (MACE). 无论患者是否接受PCI或在LT之前接受医疗管理,结果都相似.
科学领域:
- 心脏病学 心脏病学
- 移植医学 移植医学
- 干预心脏病学 干预心脏病学
背景情况:
- 冠状动脉疾病 (CAD) 在肝移植 (LT) 候选人中很普遍.
- 移植前皮肤冠状动脉干预 (PCI) 对LT后结果的益处尚不清楚.
研究的目的:
- 评估移植前的PCI是否能改善严重心血管不良事件 (MACE) 在无症状的LT候选人中.
主要方法:
- 一个单一中心对111名无症状的LT候选人与严重的CAD (2005-2025) 的队列研究.
- 进行PCI的患者 (n=66) 和医疗管理的患者 (n=45) 之间的结局比较.
- 主要终点:MACE (心肌梗塞,中风,新的静脉缩功能障碍,LT后再血管化,全因死亡).
主要成果:
- 在PCI和非PCI组之间,复合MACE没有显著差异 (52%对60%,p=0.40).
- 在细灰模型中,PCI与MACE无关.
- 独立预测MACE的预测因素包括先前的心肌梗塞和移植前透析.
结论:
- 移植前的PCI与无症状的LT候选人中严重的CAD后的LT MACE减少无关.
- 管理层决策应考虑其他风险因素,如先前的肌痛中风和透析状态.
相关概念视频
01:27Coronary Artery Disease V: Interprofessional Care
212
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
212
01:30Acute Coronary Syndrome III: Diagnostic Studies
209
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
209